Biocon arm Syngene names Sibaji Biswas as new Chief Financial Officer Medical Dialogues Bureau2 Dec 2019 9:35 AM ISTSibaji Biswas will succeed M.B. Chinappa, current CFO, who will stay within the Biocon Group of Companies and join Biocon Biologics India Ltd. in a...
Suven Life Sciences Alzheimers drug Masupirdine fails to meet primary endpoint Medical Dialogues Bureau2 Dec 2019 9:30 AM ISTSUVN-502 did not meet the pre-specified primary endpoint. Meaningful improvements and potential beneficial effects on cognitive function, behavioural...
China plans to use bulk-buy scheme to close pharmaceutical price gap Medical Dialogues Bureau2 Dec 2019 9:00 AM ISTNew Delhi: China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets,...
Eli Lilly to invest USD 400 million in Indianapolis facilities Medical Dialogues Bureau1 Dec 2019 9:30 AM ISTNew Delhi: Eli Lilly and Company recently announced plans to invest $400 million in its manufacturing facilities at its Lilly Technology Center campus...
Bayer collaborates with Pharmaron to develop new molecular entities for veterinary medicines Farhat Nasim1 Dec 2019 9:22 AM ISTNew Delhi: Bayer and Pharmaron have entered into a global collaboration agreement to develop new molecular entities for veterinary medicines.Under the...
Neuraxpharm expands operation in Southern Europe with launch of Neuraxpharm Portugal Medical Dialogues Bureau1 Dec 2019 9:00 AM ISTNeuraxpharm aims to build its position as a CNS specialist in Portugal offering its wide portfolio of branded and consumer healthcare products in the...
Health Ministry appoints 12 analysts pan India for different classes of drugs; Details Medical Dialogues Bureau30 Nov 2019 2:58 PM ISTNew Delhi: Through a recent Gazette notification, the Union Health Ministry has announced the appointment of Government Analysts in pan India in...
Aurobindo Pharma to acquire Profectus BioSciences biz assets for Rs 80 crore Medical Dialogues Bureau30 Nov 2019 9:45 AM ISTAuro Vaccines LLC is a wholly-owned subsidiary of Aurobindo Pharma USA Inc, USA, which is a wholly-owned arm of the company, Aurobindo Pharma said in...
AstraZeneca cancer drug Imfinzi gets USFDA priority review Medical Dialogues Bureau30 Nov 2019 9:40 AM ISTAstraZeneca said the USFDA accepted its supplemental application and granted priority review to Imfinzi for the treatment of previously untreated...
Cipla shares jump 2 pc post agreement with CitiHealth Imports Medical Dialogues Bureau30 Nov 2019 9:15 AM ISTNew Delhi: Shares of Cipla on Thursday rose nearly 2 per cent after the pharma major said its arm has signed an agreement with CitiHealth Imports to...
Medtronic drug-coated balloon IN.PACT AV gets USFDA nod to treat AV Fistulaes Medical Dialogues Bureau29 Nov 2019 12:33 PM ISTNew Delhi: Medtronic plc recently announced the U.S. Food and Drug Administration (USFDA) approval of the IN.PACT AV drug-coated balloon (DCB), a...
Novartis USD 90 million gene, cell therapy factory to begin Kymriah, Zolgensma production in 2020 Medical Dialogues Bureau29 Nov 2019 9:30 AM ISTNew Delhi: Swiss drugmaker Novartis's new $90 million Cell and Gene therapy factory in northern Switzerland is on track to begin commercial production...
